ArticleInternal and emergency medicine2022

Survival of patients with idiopathic pulmonary fibrosis and pulmonary hypertension under therapy with nintedanib or pirfenidone.

Donato Lacedonia et al.PubMed ↗Publisher ↗

No numbers read from the abstract.